Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 4/20 | 1.00 |
| ▸ | MAPT | P10636 | 3/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 1.00 |
| ▸ | RECQL | P46063 | 2/20 | 1.00 |
| ▸ | SOST | Q9BQB4 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 2/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 1.00 |
| ▸ | GAA | P10253 | 2/20 | 1.00 |
| ▸ | ALOX12 | P18054 | 2/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 2/20 | 1.00 |
| ▸ | POLB | P06746 | 1/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | NFKB1 | P19838 | 1/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 1/20 | 1.00 |
| ▸ | SYNJ2 | O15056 | 3/20 | 0.75 |
| ▸ | APP | P05067 | 1/20 | 0.75 |
| ▸ | XDH | P47989 | 2/20 | 0.67 |
| ▸ | IDO1 | P14902 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Taxifolin SCHEMBL29390633 | 1.00 | CYP3A4 (1.00) | CYP3A4ALOX15MAPTHSD17B10RECQL | |
| (+)-Taxifolin SCHEMBL30300501 | 1.00 | CYP3A4 (1.00) | CYP3A4ALOX15MAPTHSD17B10RECQL | |
| (+)-Taxifolin SCHEMBL30631315 | 1.00 | CYP3A4 (1.00) | CYP3A4ALOX15MAPTHSD17B10RECQL | |
| (+)-Taxifolin SCHEMBL29361519 | 1.00 | CYP3A4 (1.00) | CYP3A4ALOX15MAPTHSD17B10RECQL | |
| (+)-Taxifolin SCHEMBL13241264 | 1.00 | CYP3A4 (1.00) | CYP3A4ALOX15MAPTHSD17B10RECQL | |
| (+)-Taxifolin SCHEMBL7628142 | 1.00 | CYP3A4 (1.00) | CYP3A4ALOX15MAPTHSD17B10RECQL | |
| (+)-Taxifolin SCHEMBL296323 | 1.00 | CYP3A4 (1.00) | CYP3A4ALOX15MAPTHSD17B10RECQL | |
| (+)-Epitaxifolin SCHEMBL31575455 | 1.00 | CYP3A4 (1.00) | CYP3A4ALOX15MAPTHSD17B10RECQL | |
| (+)-Taxifolin SCHEMBL1707803 | 1.00 | CYP3A4 (1.00) | CYP3A4ALOX15MAPTHSD17B10RECQL | |
| (+)-Taxifolin SCHEMBL29367955 | 1.00 | CYP3A4 (1.00) | CYP3A4ALOX15MAPTHSD17B10RECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4243809-A2 | COMPOUNDS AND METHODS FOR TREATING VIRAL INFECTIONS | Beth Israel Deaconess Medical Center, Inc. (US) | 2023-09-20 | — | — | EP | claimed |
| WO-2022104153-A2 | COMPOUNDS AND METHODS FOR TREATING VIRAL INFECTIONS | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. (US) | 2022-05-19 | — | — | WO | claimed |
| CN-114306547-A | Traditional Chinese medicine formula for regulating and controlling intestinal function of pregnant women | 华子昂 | 2022-04-12 | — | — | CN | claimed |
| CN-114272321-A | Traditional Chinese medicine formula for regulating and controlling intestinal function of old people | 华子昂 | 2022-04-05 | — | — | CN | claimed |
| CN-114129680-A | Traditional Chinese medicine formula for promoting calcium supplement of postpartum women | 华子昂 | 2022-03-04 | — | — | CN | claimed |
| WO-2023287620-A9 | METHODS FOR TREATING CORONAVIRUS INFECTION | RABINOFF MICHAEL (US) | 2023-11-30 | — | — | WO | disclosed |
| WO-2023287620-A9 | METHODS FOR TREATING CORONAVIRUS INFECTION | RABINOFF MICHAEL (US) | 2023-11-30 | — | — | WO | disclosed |
| WO-2023287620-A1 | METHODS FOR TREATING CORONAVIRUS INFECTION | RABINOFF MICHAEL (US) | 2023-01-19 | — | — | WO | disclosed |
| WO-2023287620-A1 | METHODS FOR TREATING CORONAVIRUS INFECTION | RABINOFF MICHAEL (US) | 2023-01-19 | — | — | WO | disclosed |
| US-20220378716-A1 | FORMULATION TO REDUCE OR PREVENT OXIDATIVE STRESS DAMAGE | Cora Therapeutics Inc. (CA) | 2022-12-01 | — | — | US | disclosed |
| CN-115209892-A | Formulations for reducing or preventing oxidative stress damage | 科拉医疗股份有限公司 | 2022-10-18 | — | — | CN | disclosed |
| EP-4051261-A1 | FORMULATION TO REDUCE OR PREVENT OXIDATIVE STRESS DAMAGE | Cora Therapeutics Inc. (CA) | 2022-09-07 | — | — | EP | disclosed |
| CN-114306547-A | Traditional Chinese medicine formula for regulating and controlling intestinal function of pregnant women | 华子昂 | 2022-04-12 | — | — | CN | disclosed |
| CN-114272321-A | Traditional Chinese medicine formula for regulating and controlling intestinal function of old people | 华子昂 | 2022-04-05 | — | — | CN | disclosed |
| CN-114129680-A | Traditional Chinese medicine formula for promoting calcium supplement of postpartum women | 华子昂 | 2022-03-04 | — | — | CN | disclosed |
| CN-114007604-A | Hepatic fibrosis inhibitor and brown fat cell activator containing taxifolin | 独立行政法人国立病院机构 | 2022-02-01 | — | — | CN | disclosed |